These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11820197)

  • 1. FDA accuses Red Cross of unsafe practices. Inspections at embattled blood bank turn up 'serious' violations.
    Becker C
    Mod Healthc; 2001 Dec; 31(51):10. PubMed ID: 11820197
    [No Abstract]   [Full Text] [Related]  

  • 2. Bad blood between Red Cross and FDA.
    Gershon D
    Nature; 1990 Jul; 346(6281):210. PubMed ID: 2374578
    [No Abstract]   [Full Text] [Related]  

  • 3. How FDA safeguards the blood supply.
    Stone BW
    FDA Consum; 1991 Jun; 25(5):12-5. PubMed ID: 10111728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood investigation.
    AIDS Policy Law; 1996 May; 11(9):12. PubMed ID: 11363471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment: dilemmas of dementia.
    Dodd RY
    J Clin Ethics; 2001; 12(2):141-2. PubMed ID: 11642065
    [No Abstract]   [Full Text] [Related]  

  • 6. Pressure grows over US blood ban.
    Goodman S
    Nature; 2001 Aug; 412(6846):467. PubMed ID: 11484010
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 8. The nation's changing blood supply system.
    McCullough J
    JAMA; 1993 May; 269(17):2239-45. PubMed ID: 8474203
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA could OK costly blood standards. An expert says that like chicken soup, removal of white cells from blood supply can't hurt.
    Hensley S
    Mod Healthc; 1999 Nov; 29(48):8. PubMed ID: 10662211
    [No Abstract]   [Full Text] [Related]  

  • 11. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 12. Food and Drug Administration regulation of blood bank software: the new regulatory landscape for blood establishments and their vendors.
    Weeda DF; O'Flaherty NF
    Transfusion; 1998 Jan; 38(1):86-9. PubMed ID: 9482400
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-referencing of ISO-9000 and regulatory quality systems at blood centers.
    Healy-Collier K
    Top Health Inf Manage; 1998 May; 18(4):32-8. PubMed ID: 10179274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New variant CJD fears threaten blood supplies.
    Senior K
    Lancet; 2001 Jul; 358(9278):304. PubMed ID: 11498226
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress in blood supply safety.
    Revelle M
    FDA Consum; 1995 Apr; 29(3):21-4. PubMed ID: 10141840
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines on product liability for the hospital blood bank. The British Committee for Standards in Haematology.
    Clin Lab Haematol; 1990; 12(3):329-44. PubMed ID: 2272161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood feud.
    Sarudi D
    Hosp Health Netw; 2000 Jul; 74(7):50-6. PubMed ID: 10943226
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologics products; establishment registration and product listing for manufacturers of human blood and blood products; amendment to exempt certain transfusion services from registration--FDA. Final rule.
    Fed Regist; 1984 Aug; 49(171):34448-51. PubMed ID: 10299643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review demanded on Canadian blood.
    Science; 1992 Dec; 258(5090):1878-9. PubMed ID: 1470910
    [No Abstract]   [Full Text] [Related]  

  • 20. Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Aug; 66(151):40886-90. PubMed ID: 11732557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.